BSEBrawn Biotech LtdMinimalNeutral
Announced Mon, 30 Mar · 10:23 IST

Closure of Trading Window from 01st April 2026 till 48 hours after the declaration of financial results for the quarter and financial year ended 31st March 2026.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
1-day move
₹20.85
prior close
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-5.0-4.1-6.4-1.8-0.2+1.0-1.4
Up moveDown movePending
AI summary

Brawn Biotech Ltd has informed the stock exchanges that its trading window will be closed starting 01 April 2026. The window will remain shut until 48 hours after the company declares its audited financial results for the fourth quarter and full financial year ended 31 March 2026. During this period, designated persons (insiders) and their immediate relatives are prohibited from buying or selling the company's shares. The blackout is being implemented in line with the company's insider trading code, which follows SEBI's Prohibition of Insider Trading Regulations, 2015. The exact date of the board meeting to approve the results will be communicated later. This is a routine compliance filing ahead of the annual results announcement.

Likely market impact

This is a standard regulatory filing and does not directly affect shareholders. However, it signals that the company's Q4 and FY26 audited results announcement is imminent, which could be a near-term catalyst for the stock depending on the numbers declared.